1. Home
  2. MNKD vs BWIN Comparison

MNKD vs BWIN Comparison

Compare MNKD & BWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • BWIN
  • Stock Information
  • Founded
  • MNKD 1991
  • BWIN 2011
  • Country
  • MNKD United States
  • BWIN United States
  • Employees
  • MNKD N/A
  • BWIN N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • BWIN Specialty Insurers
  • Sector
  • MNKD Health Care
  • BWIN Finance
  • Exchange
  • MNKD Nasdaq
  • BWIN Nasdaq
  • Market Cap
  • MNKD 1.7B
  • BWIN 1.7B
  • IPO Year
  • MNKD 2004
  • BWIN 2019
  • Fundamental
  • Price
  • MNKD $5.33
  • BWIN $23.61
  • Analyst Decision
  • MNKD Strong Buy
  • BWIN Hold
  • Analyst Count
  • MNKD 5
  • BWIN 8
  • Target Price
  • MNKD $10.80
  • BWIN $38.86
  • AVG Volume (30 Days)
  • MNKD 4.4M
  • BWIN 916.0K
  • Earning Date
  • MNKD 11-05-2025
  • BWIN 11-04-2025
  • Dividend Yield
  • MNKD N/A
  • BWIN N/A
  • EPS Growth
  • MNKD 149.32
  • BWIN N/A
  • EPS
  • MNKD 0.11
  • BWIN N/A
  • Revenue
  • MNKD $301,736,000.00
  • BWIN $1,461,046,000.00
  • Revenue This Year
  • MNKD $14.78
  • BWIN $10.87
  • Revenue Next Year
  • MNKD $19.36
  • BWIN $12.60
  • P/E Ratio
  • MNKD $50.09
  • BWIN N/A
  • Revenue Growth
  • MNKD 21.48
  • BWIN 11.44
  • 52 Week Low
  • MNKD $3.38
  • BWIN $22.15
  • 52 Week High
  • MNKD $7.63
  • BWIN $51.55
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 49.48
  • BWIN 33.34
  • Support Level
  • MNKD $5.28
  • BWIN $23.23
  • Resistance Level
  • MNKD $5.62
  • BWIN $24.58
  • Average True Range (ATR)
  • MNKD 0.24
  • BWIN 1.12
  • MACD
  • MNKD -0.02
  • BWIN -0.03
  • Stochastic Oscillator
  • MNKD 58.80
  • BWIN 20.48

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About BWIN The Baldwin Insurance Group Inc. Class A Common Stock

The Baldwin Insurance Group Inc is a United States-based insurance distribution firm. Its products include Business Insurance, Benefits Consulting, Reinsurance, Specialty MGA, Embedded Insurance., Personal insurance, etc.

Share on Social Networks: